10-K Decoder · All companies

Krystal Biotech, Inc.

KRYS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$389M$291M+33.9%
Operating income$161M$65.8M+145%
Net income$205M$89.2M+130%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 2, 2026

$Q3 2026Year earlierChange
Revenue$127M$97.8M+30.2%
Operating income$71.1M$41.4M+71.7%
Net income$63.1M$79.4M−20.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Krystal Biotech's revenue in FY2025?
$389M in FY2025 (Fiscal year ended Dec 31, 2025), +33.9% vs $291M a year earlier, per its 10-K filed Feb 2026.
Was Krystal Biotech profitable in FY2025?
Yes: net income was $205M and operating income $161M in FY2025.
What was Krystal Biotech's revenue in Q3 2026?
$127M (+30.2% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.